Navigating Uncertain Times
Asked about the hardest stretch of our listing preparation, our Senior Managing Director wrote that he struggles to answer: "It was an endless series of firsts, so it was always hard — but once done, it's done, and I barely remember the hardship. The thrill of moving forward outweighed it."
The one pain he did name: not knowing — how long it would take, how much it would cost, walls appearing one after another. What kept him going? "The companions. People who answered 'Let's challenge it positively!' with 'Yes, let's!' — that was everything." When the road has no map, what works is not a map but the face walking beside you.
Do you have someone who says "yes, let's" — and are you that someone for anyone?
What do you work for?
— Tomoki Nagano, Chairman & CEO, INSTINCT BIO TECHNICAL COMPANY (NASDAQ: BIOT)
Next Essay
From the Day After Our First Dinner, Always Together
Read →About the Company
The Nasdaq-listed company where the author serves as Chairman.
- Business →Stem-cell cosmetics R&D, OEM/ODM manufacturing, and in-house brands
- Investor Relations →BIOT stock price, SEC filings, and governance
- Company & Governance →Company profile and leadership
This series reflects the personal views of the author. It is not an earnings forecast, a valuation of any security, or a solicitation to invest.